Profile

I have been working in cancer immunotherapy since 2011 on both novel therapeutics development and diagnostics development. During that time, I have served as a manuscript reviewer and associate editor for Journal of Translational Medicine, participated in forums for public education (both industry specific and to a general audience), led the immunogenic cell death working group of the SITC Cancer Immune Response Task Force, and participated in educational outreach opportunities to graduate students, undergrads, and high school students. I am able to speak about the biotech industry, working in startup and mid-sized companies, diagnostics development, drug development, and being a woman in a STEM field.